Living Well With Myeloma

Mar
23
Living Well with Myeloma: Novel Agents & Clinical Trials 2017
Dr. Craig Cole (University of Michigan Comprehensive Cancer Center) gives an update on the novel agents currently used to treat multiple myeloma and how clinical trials benefit patients.
Jan
12
Best of ASH 2016
Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma(...)
Nov
16
Pre-ASH: What Myeloma Patients & Caregivers Need to Know
click on the image above to watch the teleconference (to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo) IMF’s Chairman of the Board Dr. Brian G.(...)
Sep
23
CAR T-Cell Therapy: What Patients & Caregivers Need to Know
Dr. Rafat Abonour (Indiana University – Simon Cancer Center) and Dr. Edward Stadtmauer (University of Pennsylvania). CAR T cells, or chimeric antigen receptor T cells, are part of a class of cancer(...)
May
20
Living Well with Myeloma: What You Need to Know to Overcome Side Effects from Novel Therapies
Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN Cleveland Clinic Taussig Cancer Institute Multiple Myeloma Program Cleveland, OH Kevin Brigle, PhD, NP VCUHS Massey Cancer Center Richmond, VA
Mar
03
Living Well with Myeloma: IMF's Expert Panel Answers Your Top Concerns
An IMF expert panel answers your top concerns. The panelists include Drs. Brian Durie, Rafat Abonour, and S. Vincent Rajkumar.